descriptionPublicationkeyboard_double_arrow_right Article , Other literature type 01 Mar 2019Publisher:MediaSphere Medical LLCJournal:Journal of Innovations in Cardiac Rhythm Management, volume 0, pages 3,588-3,591 (issn: 2156-3977, eissn: 2156-3993,

Authors: Kalola, Ankur S.; Dean, Robert;

doi: 10.19102/icrm.2019.100305

pmid: 32477722

pmc: PMC7252651

The United States Food and Drug Administration and Prescription Drug Promotion

- Summary
- Subjects
- Metrics

Abstract

The impact of prescription drug promotion on health-care professionals (HCPs) is significant. Pharmaceutical industry spending on promotion to HCPs greatly outpaces spending on direct-to-consumer promotion. According to Syneos Health™ PromotionalAnswers, in 2017, the pharmaceutical industry spent more than $24 billion on drug promotion, with more than $18.5 billion allotted for marketing to HCPs. Although prescription drug promotion can provide valuable information about drug therapies, it is essential that it be truthful, balanced, and not misleading, because HCPs may consider this information when making treatment decisions for their patients.

Related Organizations

United States Food and Drug Administration
United States

Keywords

Research Review

Impact byBIP!

	selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	2
	popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.	Average
	influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).	Average
	impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.	Average